The FDA has denied Stealth BioTherapeutics’ request to reconsider its complete response letter, leaving the fate of the biotech and its investigational treatment for an ultrarare genetic disease ...
In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
Ruthenium has emerged as a pivotal metal in modern medicine, drug discovery, and biotechnology, with its integration into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback